PMID: 38079178
We chose this dose of semaglutide because it was in a range previously shown to cause atherosclerosis reduction in Ldlr / mice over a similar treatment schedule (14)
A consultation with our team will confirm your eligibility before any treatment begins
Being proactive, researching prices, understanding insurance coverage, and seeking assistance programs can play a significant role in managing expenses
Inzucchi, MD, Professor of Medicine, Yale University School of Medicine, who will describe stroke outcomes in SOUL John Deanfield, MB, BChir, FRCP, FESC, FACC, Professor of Cardiology, University College London, United Kingdom, who will comment on the clinical context of the SOUL trial findings from a cardiologists perspective